TBTC Study 26 PK: Rifapentine pharmacokinetics in children receiving once weekly rifapentine and isoniazid for the treatment of latent tuberculosis infection.

Trial Profile

TBTC Study 26 PK: Rifapentine pharmacokinetics in children receiving once weekly rifapentine and isoniazid for the treatment of latent tuberculosis infection.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 24 Aug 2008

At a glance

  • Drugs Isoniazid (Primary) ; Rifapentine (Primary)
  • Indications Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Aug 2008 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
    • 24 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top